Patients with blood cancer can be spared chemotherapy with two daily tablets

Patients with blood cancer can be spared chemotherapy with two daily tablets Two daily tablets could soon spare some blood cancer patients from having to go through gruelling bouts of chemotherapy.

The drug, called ruxolitinib, can keep a type of blood cancer called polycythaemia vera in remission for up to three years longer than traditional methods, according to British research. The Daily Mail

See also: 

• Incurable blood cancer trial finds new drug better than current second line treatments University of Birmingham